Announcement • 20h
Terra Innovatum Global N.V. Receives Notice of Nasdaq Listing Non-Compliance Due to Delayed SEC Filings On May 19, 2026, Terra Innovatum Global N.V. (the “Company”) received an expected deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) and as a result of remaining delinquent in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Form 10-K”), as required for continued listing on The Nasdaq Global Select Market. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq Global Select Market. In accordance with Nasdaq’s listing rules, the Company has until June 15, 2026, to submit a plan to regain compliance with respect to the filing requirements. If the Company submits a plan to Nasdaq and Nasdaq accepts the plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of the filing of the 2025 Form 10-K (as extended pursuant to Rule 12b-25 under the Securities Act of 1933, as amended (the “Securities Act”)), or until October 12, 2026, to regain compliance. The Company intends to regain compliance with Nasdaq’s listing rules as soon as practicable. Announcement • Apr 19
Terra Innovatum Global N.V. Receives Notice of Non-Compliance with Nasdaq Listing Rule On April 16, 2026, Terra Innovatum Global N.V. (the Company) received an expected deficiency letter (the Notice) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the Form 10-K), as required for continued listing on The Nasdaq Global Select Market. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq Global Select Market. In accordance with Nasdaq's listing rules, the Company has 60 calendar days, or until June 15, 2026, to submit a plan to regain compliance with respect to the filing requirement. If the Company submits a plan to Nasdaq and Nasdaq accepts the plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of the filing of the 2025 Form 10-K (as extended pursuant to Rule 12b-25 under the Securities Act of 1933, as amended (the Securities Act)), or until October 12, 2026, to regain compliance. The Company intends to regain compliance with Nasdaq's listing rules as soon as practicable. Announcement • Apr 16
Terra Innovatum Global N.V. and Mersen Achieve Graphite Prototype Manufacturing and Validation Milestone to Support First Deployment of Solo Micro-Reactor Terra Innovatum Global N.V. and Mersen announced the successful production of a graphite reactor core prototype marking an important step in manufacturing readiness for its FOAK reactor deployment. The milestone highlights the companies’ collaboration in advancing next-generation nuclear technologies. It demonstrates also Terra Innovatum’s progress in converting supply chain preparation into manufacturing execution as it advances toward FOAK deployment and NOAK commercialization. The milestone builds on Terra Innovatum’s previously announced agreement with Mersen securing nuclear-grade graphite and procurement of critical materials required for SOLO FOAK deployment targeted for 2027 and NOAK commercialization beginning in 2028. Leveraging Mersen’s expertise in nuclear-grade materials, the companies successfully produced a graphite prototype (i.e. an engineering prototype) to support SOLO FOAK development. The graphite engineering prototype has been successfully manufactured to required tolerances, validating reactor system integration and readiness for scalable, serialized production. The development of this graphite engineering prototype represents a meaningful technical milestone in the realization of the SOLO reactor core. These components are designed to host critical systems and core elements that influence thermal performance, and overall system reliability. This work also establishes the procedures and quality standards required for repeatable manufacturing and scalable deployment. SOLO will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment. Announcement • Mar 31
Terra Innovatum Global N.V. announced delayed annual 10-K filing On 03/30/2026, Terra Innovatum Global N.V. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Announcement • Mar 10
Terra Innovatum Global N.V. to Report Fiscal Year 2025 Results on Apr 01, 2026 Terra Innovatum Global N.V. announced that they will report fiscal year 2025 results at 9:30 AM, US Eastern Standard Time on Apr 01, 2026 Announcement • Mar 06
Terra Innovatum Global N.V. Announces U.S. Nuclear Regulatory Commission Docket Solo Micro-Modular Reactor Topical Reports Terra Innovatum Global N.V., developer of the SOLO Micro-Modular Reactor, announced that the U.S. Nuclear Regulatory Commission (NRC) has formally docketed several key topical reports supporting the licensing of the SOLO reactor design. Docketing represents an important regulatory milestone in the U.S. nuclear licensing process and it means that the NRC has determined that Terra Innovatum’s submissions contain sufficient technical information to begin detailed safety and design evaluation as part of the Construction Permit and Operating License Application. With the docketing of these reports, the SOLO Micro-Modular Reactor has formally entered the NRC’s technical review process, advancing the company’s regulatory pathway toward approval to construct and operate its first reactor. The docketed submissions include: SOLO Nuclear Reactor Principal Design Criteria, SOLO Project Quality Assurance Plan, SOLO Safeguards Methodology and Implementation of Material Control & Accountancy (MC&A), SOLO Nuclear Design. Together, these reports outline the fundamental engineering, safety, and regulatory framework for the SOLO reactor and support the broader licensing pathway required for reactor construction and operation. Following docketing, the NRC has initiated its technical audit phase — a standard component of the agency’s review process that allows regulators to examine supporting analyses, methodologies, and design implementation in detail. The review will culminate in the preparation of NRC Safety Evaluations (SEs) for each topical area. Safety Evaluation determinations are currently anticipated by October 2026. Completion of these reviews would represent a major regulatory milestone supporting Terra Innovatum’s targeted timeline for first-of-a-kind deployment of the SOLO reactor in 2027 and broader commercial deployment beginning in 2028. Terra Innovatum is pursuing a dual-licensing strategy with the U.S. Nuclear Regulatory Commission (NRC), advancing both Construction Permit and Operating License pathways for the SOLO Micro-Modular Reactor in parallel. This approach is enabled by the company’s decision to deploy the same reactor design for its first-of-a-kind (FOAK) unit and its future commercial fleet. As a result, key elements of the reactor design, safety systems, and regulatory framework are being reviewed with commercialization in mind from the outset. By advancing the Construction Permit and Operating License pathways concurrently, Terra Innovatum aims to streamline regulatory review and reduce the time required to transition from first deployment to broader commercial rollout. The NRC’s docketing of the SOLO topical reports marks the beginning of formal technical evaluation of the design elements supporting this licensing strategy. Terra Innovatum’s licensing program is progressing through several key regulatory milestones: 2026 — NRC technical review of SOLO topical reports; Late 2026 — NRC Safety Evaluations (SEs) of the set of Topical Reports expected; 2027 — Targeted Construction Permit and first-of-a-kind operating authorization; 2028 — Targeted initial commercial fleet deployment. Completion of these milestones would position Terra Innovatum among the first companies advancing next-generation micro-modular nuclear reactor technology toward commercial deployment. Announcement • Dec 19
Terra Innovatum Global N.V. Advances Nrc Licensing of Solo™? Reactor Licensing Through Expanded Regulatory Submissions Terra Innovatum Global N.V. announced continued substantive progress in the licensing of its SOLO Micro-Modular Reactor (MMR) through active engagement with the U.S. Nuclear Regulatory Commission (NRC), reinforcing the company's position at the forefront of next-generation nuclear deployment. Despite the federal government shutdown, during the last quarter of 2025, Terra Innovatum has had in excess of 10 face-to-face presentation and online meetings with the NRC in which the Company has detailed a comprehensive suite of technical and regulatory submittals addressing crucial-to-approval topics such as reactor design maturity, safety philosophy, and deployment readiness. These engagements reflect a deliberate licensing strategy aligned with the NRC's regulatory framework for low-con sequence reactors, a unique pathway ideally suited to the SOLO™? MMR. The rapid cadence of the Company's engagement with the NRC is aimed at securing both construction and commercial licenses for the SOLO reactor as quickly as possible to address demand from both public and private sector off-takers. Key licensing updates and activities presented to the NRC in the last quarter of 2025 include: Reactor Module and Internals Topical Report -- A detailed description of the SOLO reactor module architecture and internal systems, supporting early NRC familiarity with the integrated design. Core Design Topical Report -- Presentation of SOLO's core design, the company's key innovation, demonstrating the ability to utilize commercially available Low Enriched Uranium (LEU) fuel below 5% U-235 and traditional zircaloy-clad fuel rods with more than five decades of operating history in commercial reactors, significantly reducing fuel qualification and supply-chain risk. Announcement • Nov 18
Terra Innovatum Global N.V. announced delayed 10-Q filing On 11/17/2025, Terra Innovatum Global N.V. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Announcement • Nov 06
Terra Innovatum Global N.V. to Report Q3, 2025 Results on Nov 17, 2025 Terra Innovatum Global N.V. announced that they will report Q3, 2025 results Pre-Market on Nov 17, 2025 
